Hadassah

Thyroid Cancer Diagnosis Enhanced at Hadassah Using Advanced Gene Sequencing

Thursday, Aug 2 2018

left: Dr.Iddo Ben-Dov and right: Prof.Haggi Mazeh

Hadassah Medical Organization researchers, using next generation sequencing (NGS), have identified a highly accurate RNA panel that distinguishes thyroid cancer from benign nodules.

The study, authored by Prof. Haggi Mazeh, Chief of Surgery at Hadassah Hospital Mount Scopus, and Hadassah Nephrologist Dr. Iddo Ben-Dov, is highlighted in the July 26, 2018 on line issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

As the authors explain, fine needle aspiration biopsy (FNAB), the gold-standard procedure for diagnosing malignant thyroid nodules, yields indeterminate cytology in 10 to 40 percent of cases. The aim of their study was to utilize NGS technology to identify diversities in the microRNA expression profile of benign versus malignant thyroid nodules. MicroRNAs are short, non-coding RNAs that regulate cell function and play a role in cancer development.

"Thyroid nodules are extremely common and occasionally harbor cancer," explains Prof. Mazeh. "Patients who undergo evaluation of thyroid nodules often receive ambiguous results, and there are currently limited options for further management, representing a clinically unmet need."

“Our panel,” the researchers concluded, “may classify indeterminate thyroid nodules with higher accuracy than commercially available molecular tests.”

Read more about this study in Medical Xpress.

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, Aug 20 2018

Delicate Cataract Surgery Performed by Hadassah Hospital Specialist

Dr. Charlotte Slopak Goller had suffered from bad vision her whole life. As a child, she found herself constantly needing thicker and thicker glasses. Only in high school did an optometrist correctly diagnose her condition as keratoconus, a disorder that results in progressive thinning of the cornea.

READ MORE ›
alt_text

Friday, Aug 17 2018

Hadassah Mourns the Loss of Aretha Franklin and Urges Greater Awareness of Diagnosis and Treatment of Pancreatic Cancer

Sadly, the “queen of soul” Aretha Franklin passed away yesterday at age 76, due to an advanced pancreatic neuroendocrine tumor (pancreatic NET or PNET).

READ MORE ›
alt_text

Wednesday, Aug 15 2018

Hadassah Hospital’s Bone Marrow Transplant Department Receives International Acclaim

In a first for Israel, Hadassah Medical Organization’s Bone Marrow Transplantation and Cancer Immunotherapy Department has recently received full accreditation by the Joint Accreditation Committee ISCT-EUROPE & EBMT (JACIE), Europe’s only official accreditation body in the field.

READ MORE ›
alt_text

Tuesday, Aug 14 2018

Hadassah Hospital Helps Educate Mikvah Attendants To Bolster Women’s Health

After a woman emerges from the ritual bath (mikveh) and wraps herself in a towel, says mikveh attendant Daniella Salomon, “I keep an eye out” for anything unusual.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More